Back to search

Article

Resistance to vincristine in cancerous B-cells by disruption of p53-dependent mitotic surveillance

2023-01-20

Abstract excerpt

The frontline therapy R-CHOP for patients with diffuse large B-cell lymphoma (DLBCL) has remained unchanged for two decades despite numerous phase III clinical trials investigating new alternatives. Multiple large studies have uncovered genetic subtypes of DLBCL enabling a targeted approach. To further pave the way for precision oncology, we perform genome-wide CRISPR screening to uncover the cellular response to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8509cb5c-5319-58e0-b02c-3c3a1fac0da8
DOI
10.1101/2023.01.19.524713
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resistance to vincristine in cancerous B-cells by disruption of p53-dependent mitotic surveillanceDOI 10.1101/2023.01.19.524713
Select a neighboring publication to make it the new centre.